MAPT and Alzheimer disease: In terms of p-tau, the dementia with Lewy bodies group had a higher frequency of a positive p-tau biomarker than the cognitively unimpaired and mild cognitive impairment groups, but a lower frequency than the Alzheimer’s disease group.